2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

被引：162

作者：

Landmesser, Ulf

Chapman, M. John

Stock, Jane K.

Amarenco, Pierre

Belch, Jill J. F.

Boren, Jan

Farnier, Michel

Ference, Brian A.

Gielen, Stephan

Graham, Ian

机构：

[1] Department of Cardiology, Charite Universitätsmedizin Berlin, Berlin Institute of Health (BIH), German Center of Cardiovascular Research (DZHK), Hindenburgdamm 30, Berlin

[2] National Institute for Health and Medical Research (INSERM), University of Pierre and Marie Curie, Pitié-Salpêtrière Hospital, Paris

[3] European Atherosclerosis Society, Gothenburg

[4] Paris-Diderot-Sorbonne University, Department of Neurology and Stroke Centre, Bichat Hospital, Paris

[5] Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee

[6] Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg

[7] Lipid Clinic, Point Medical, Department of Cardiology, CHU Dijon-Bourgogne, Dijon

[8] Division of Cardiovascular Medicine, Division of Translational Research and Clinical Epidemiology, Wayne State University School of Medicine, Detroit, MI

[9] Department of Internal Medicine III, Martin-Luther-University Halle/Wittenberg, University Hospital, Halle/Saale

[10] Trinity College, Dublin

[11] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht

[12] Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam

[13] University Heart Center, Department of Cardiology, University Hospital Zurich, Center for Molecular Cardiology, University of Zurich, Zurich

[14] Heart Failure Unit, Cardiac Department, G da Saliceto Hospital, Piacenza

[15] Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London

[16] Sahlgrenska University Hospital, Gothenburg

[17] Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern

[18] Department of Cardiology, University Hospital Ramón y Cajal, Madrid

[19] Cardiology Department, CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa

[20] Department of Cardiology, Hacettepe University, Ankara

[21] Department of Cardiology, Leiden University Medical Center, Leiden

[22] Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCSS Milano

来源：

EUROPEAN HEART JOURNAL | 2018年 / 39卷 / 14期

关键词：

DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; LONG-TERM SAFETY; MONOCLONAL-ANTIBODY; STATIN THERAPY; COST-EFFECTIVENESS; PCSK9; INHIBITORS; FOLLOW-UP; RISK; ALIROCUMAB;

D O I：

10.1093/eurheartj/ehx549

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1131 / 1143

页数：90

共 52 条

[1] Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry [J].

Alberts, Mark J. ;

Bhatt, Deepak L. ;

Mas, Jean-Louis ;

Ohman, E. Magnus ;

Hirsch, Alan T. ;

Roether, Joachim ;

Salette, Genevieve ;

Goto, Shinya ;

Smith, Sidney C., Jr. ;

Liau, Chiau-Suong ;

Wilson, Peter W. F. ;

Steg, Ph. Gabriel .

EUROPEAN HEART JOURNAL, 2009, 30 (19) :2318-2326

[2] Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors [J].

Alonso, R. ;

Mata, N. ;

Castillo, S. ;

Fuentes, F. ;

Saenz, P. ;

Muniz, O. ;

Galiana, J. ;

Figueras, R. ;

Diaz, J. L. ;

Gomez-Enterria, P. ;

Mauri, M. ;

Piedecausa, M. ;

Irigoyen, L. ;

Aguado, R. ;

Mata, P. .

ATHEROSCLEROSIS, 2008, 200 (02) :315-321

[3] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[4] Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].

Benn, Marianne ;

Watts, Gerald F. ;

Tybjaerg-Hansen, Anne ;

Nordestgaard, Borge G. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964

[5] Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy [J].

Cannon, Christopher P. ;

Steinberg, Benjamin A. ;

Murphy, Sabina A. ;

Mega, Jessica L. ;

Braunwald, Eugene .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) :438-445

[6] The efficacy and safety of ezetimibe coadministered with statin therapy in various patient groups [J].

Catapano, Alberico ;

Toth, Peter P. ;

Tomassini, Joanne E. ;

Tershakovec, Andrew M. .

CLINICAL LIPIDOLOGY, 2013, 8 (01) :13-41

[7] Coronary Computed Tomographic Angiography and Risk of All-Cause Mortality and Nonfatal Myocardial Infarction in Subjects Without Chest Pain Syndrome From the CONFIRM Registry (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) [J].

Cho, Iksung ;

Chang, Hyuk-Jae ;

Sung, Ji Min ;

Pencina, Michael J. ;

Lin, Fay Y. ;

Dunning, Allison M. ;

Achenbach, Stephan ;

Al-Mallah, Mouaz ;

Berman, Daniel S. ;

Budoff, Matthew J. ;

Callister, Tracy Q. ;

Chow, Benjamin J. W. ;

Delago, Augustin ;

Hadamitzky, Martin ;

Hausleiter, Joerg ;

Maffei, Erica ;

Cademartiri, Filippo ;

Kaufmann, Philipp ;

Shaw, Leslee J. ;

Raff, Gil L. ;

Chinnaiyan, Kavitha M. ;

Villines, Todd C. ;

Cheng, Victor ;

Nasir, Khurram ;

Gomez, Millie ;

Min, James K. .

CIRCULATION, 2012, 126 (03) :304-+

[8] Interpretation of the evidence for the efficacy and safety of statin therapy [J].

Collins, Rory ;

Reith, Christina ;

Emberson, Jonathan ;

Armitage, Jane ;

Baigent, Colin ;

Blackwell, Lisa ;

Blumenthal, Roger ;

Danesh, John ;

Smith, George Davey ;

DeMets, David ;

Evans, Stephen ;

Law, Malcolm ;

MacMahon, Stephen ;

Martin, Seth ;

Neal, Bruce ;

Poulter, Neil ;

Preiss, David ;

Ridker, Paul ;

Roberts, Ian ;

Rodgers, Anthony ;

Sandercock, Peter ;

Schulz, Kenneth ;

Sever, Peter ;

Simes, John ;

Smeeth, Liam ;

Wald, Nicholas ;

Yusuf, Salim ;

Peto, Richard .

LANCET, 2016, 388 (10059) :2532-2561

[9] Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review [J].

De Vera, Mary A. ;

Bhole, Vidula ;

Burns, Lindsay C. ;

Lacaille, Diane .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) :684-698

[10] Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry [J].

deGoma, Emil M. ;

Ahmad, Zahid S. ;

O'Brien, Emily C. ;

Kindt, Iris ;

Shrader, Peter ;

Newman, Connie B. ;

Pokharel, Yashashwi ;

Baum, Seth J. ;

Hemphill, Linda C. ;

Hudgins, Lisa C. ;

Ahmed, Catherine D. ;

Gidding, Samuel S. ;

Duffy, Danielle ;

Neal, William ;

Wilemon, Katherine ;

Roe, Matthew T. ;

Rader, Daniel J. ;

Ballantyne, Christie M. ;

Linton, MacRae F. ;

Duell, P. Barton ;

Shapiro, Michael D. ;

Moriarty, Patrick M. ;

Knowles, Joshua W. .

CIRCULATION-CARDIOVASCULAR GENETICS, 2016, 9 (03) :240-+

← 1 2 3 4 5 6 →